Related Experiment Video
Updated: Jan 7, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Breakfast skipping and steroid withdrawal in ulcerative colitis: A population-based study in Japan
Hiroshi Fukuda1, Haru Miyagi1, Kenta Yamamoto1
1Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Tokyo, Japan.
None:
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with increasing prevalence in Japan. While pharmacological therapies have advanced, the effect of dietary timing, particularly breakfast skipping, on disease course remains unclear. We conducted a retrospective cohort study using the JMDC database (2015-2023), which contains claims and annual health checkup data from about 8.17 million insured individuals. We identified 1645 UC patients who initiated corticosteroid therapy within 1 year after diagnosis and were followed for at least 3 years. Breakfast skipping was defined as skipping breakfast more than three times per week. The primary outcome was steroid withdrawal, defined as discontinuation of corticosteroid prescriptions. Logistic regression models estimated odds ratios (ORs) and 95% confidence intervals (CIs) for steroid withdrawal according to breakfast habits. Among 1645 patients, 303 (18.4%) reported skipping breakfast. Steroid withdrawal occurred in 543 patients (33.0%), including 108 (35.6%) in the breakfast skipping group and 435 (32.4%) in the breakfast consuming group. In fully adjusted models accounting for 5-aminosalicylic acid and immunosuppressant use, breakfast skipping was associated with higher odds of steroid withdrawal (OR 1.52, 95% CI 1.08-2.14). These findings suggest that meal timing may influence sustained remission in UC.
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Bioavailability Study Design: Healthy Subjects Versus Patients

